<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://articlefeeds.nasdaq.com/~d/styles/itemcontent.css"?><rss xmlns:a10="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel xmlns:nasdaq="http://nasdaq.com/reference/feeds/1.0/">
    <title>Latest Articles about NUS</title>
    <description />
    <language>EN-US</language>
    <lastBuildDate>Sun, 19 May 2013 06:53:17 -0400</lastBuildDate>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://articlefeeds.nasdaq.com/nasdaq/symbols?symbol=NUS" /><feedburner:info uri="nasdaq/symbols" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item xml:base="http://www.nasdaq.com/article/neutral-on-international-flavors-fragrances-analyst-blog-cm246990">
      <guid isPermaLink="false">246990</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FjJYcL7-ucQ/neutral-on-international-flavors-fragrances-analyst-blog-cm246990</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Neutral on International Flavors &amp; Fragrances - Analyst Blog</title>
      <description>Recently, we reiterated a Neutral recommendation on New York-based  International Flavors &amp;amp; Fragrances Inc.  (  IFF  ), one of the leading creators and manufacturers of fragrance and&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/FjJYcL7-ucQ" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 17 May 2013 21:30:04 Z</pubDate>
      <a10:updated>2013-05-17T18:32:12Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AVP</nasdaq:tickers>
      <nasdaq:tickers>IFF</nasdaq:tickers>
      <nasdaq:tickers>IPAR</nasdaq:tickers>
      <nasdaq:tickers>NUS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/neutral-on-international-flavors-fragrances-analyst-blog-cm246990</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/colgate-retains-neutral-view-analyst-blog-cm246816">
      <guid isPermaLink="false">246816</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JcCbZ3KlQAs/colgate-retains-neutral-view-analyst-blog-cm246816</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Colgate Retains Neutral View - Analyst Blog</title>
      <description>We have maintained our long-term Neutral recommendation on the global consumer products company,  Colgate-Palmolive Company  (  CL  ) with a target price of $127.00, following its first-quarter&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/JcCbZ3KlQAs" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 17 May 2013 03:28:31 Z</pubDate>
      <a10:updated>2013-05-17T00:28:53Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AVP</nasdaq:tickers>
      <nasdaq:tickers>CL</nasdaq:tickers>
      <nasdaq:tickers>NUS</nasdaq:tickers>
      <nasdaq:tickers>ZEP</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/colgate-retains-neutral-view-analyst-blog-cm246816</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/iff-beats-earnings-lags-rev-in-1q-analyst-blog-cm244200">
      <guid isPermaLink="false">244200</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KPUsRKQoZvk/iff-beats-earnings-lags-rev-in-1q-analyst-blog-cm244200</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>IFF Beats Earnings; Lags Rev in 1Q - Analyst Blog</title>
      <description>International Flavors &amp;amp; Fragrances Inc.  (   IFF  ) reported  first-quarter 2013 adjusted earnings per share of $1.19, up 19.0%  from a year-ago earnings of $1.00. Results beat the&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/KPUsRKQoZvk" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 07 May 2013 17:29:31 Z</pubDate>
      <a10:updated>2013-05-07T13:30:02Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AVP</nasdaq:tickers>
      <nasdaq:tickers>IFF</nasdaq:tickers>
      <nasdaq:tickers>MEOH</nasdaq:tickers>
      <nasdaq:tickers>NUS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/iff-beats-earnings-lags-rev-in-1q-analyst-blog-cm244200</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/iff-to-shut-down-augusta-facility-analyst-blog-cm244016">
      <guid isPermaLink="false">244016</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7mqsJbj0L-4/iff-to-shut-down-augusta-facility-analyst-blog-cm244016</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>IFF to Shut Down Augusta Facility - Analyst Blog</title>
      <description>New York City-based flavors and fragrances major,  International Flavors &amp;amp; Fragrances Inc.  (  IFF  ) recently announced plans to shut down the Augusta, Georgia based Fragrances&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/7mqsJbj0L-4" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 07 May 2013 02:20:01 Z</pubDate>
      <a10:updated>2013-05-06T23:25:56Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AVP</nasdaq:tickers>
      <nasdaq:tickers>IFF</nasdaq:tickers>
      <nasdaq:tickers>MEOH</nasdaq:tickers>
      <nasdaq:tickers>NUS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/iff-to-shut-down-augusta-facility-analyst-blog-cm244016</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/avon-posts-strong-1q-earnings-analyst-blog-cm242122">
      <guid isPermaLink="false">242122</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/liC-gSnhjho/avon-posts-strong-1q-earnings-analyst-blog-cm242122</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>Avon Posts Strong 1Q Earnings - Analyst Blog</title>
      <description>The global beauty company,  Avon Products Inc  . (  AVP  ) commenced fiscal 2013 on a strong note by posting adjusted earnings per share of 26 cents for the first quarter owing to&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/liC-gSnhjho" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 30 Apr 2013 18:52:33 Z</pubDate>
      <a10:updated>2013-04-30T15:57:10Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AVP</nasdaq:tickers>
      <nasdaq:tickers>IPAR</nasdaq:tickers>
      <nasdaq:tickers>LRLCY</nasdaq:tickers>
      <nasdaq:tickers>NUS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/avon-posts-strong-1q-earnings-analyst-blog-cm242122</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/chuck-royce-buys-stifel-financial-tidewater-alamos-sells-kennametal-gardner-denver-gartner-cm240629">
      <guid isPermaLink="false">240629</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1vrYgM6ZjFI/chuck-royce-buys-stifel-financial-tidewater-alamos-sells-kennametal-gardner-denver-gartner-cm240629</link>
      <category>Investing</category>
      <title>Chuck Royce Buys Stifel Financial, Tidewater, Alamos, Sells Kennametal, Gardner Denver, Gartner</title>
      <description>Small cap Guru  Chuck Royce  just reported his first quarter portfolio. Royce Premier Fund (  RYPRX  ) has gained 6% a year over the past 5 years while the S&amp;amp;P 500 gained just 1.5% a&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/1vrYgM6ZjFI" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 25 Apr 2013 19:09:38 Z</pubDate>
      <a10:updated>2013-04-25T16:11:01Z</a10:updated>
      <author>GuruFocus</author>
      <nasdaq:tickers>FII</nasdaq:tickers>
      <nasdaq:tickers>LECO</nasdaq:tickers>
      <nasdaq:tickers>NUS</nasdaq:tickers>
      <nasdaq:tickers>RS</nasdaq:tickers>
      <nasdaq:tickers>RYPRX</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/chuck-royce-buys-stifel-financial-tidewater-alamos-sells-kennametal-gardner-denver-gartner-cm240629</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/is-nu-skin-poised-to-revive-faster-earnings-growth-cm238843">
      <guid isPermaLink="false">238843</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cSj3zYfPPDE/is-nu-skin-poised-to-revive-faster-earnings-growth-cm238843</link>
      <category>Personal Finance</category>
      <category>Investing Ideas</category>
      <title>Is Nu Skin Poised To Revive Faster Earnings Growth?</title>
      <description>In November 2008, IBD reported thatNu Skin Enterprises (    NUS     ) would launch an anti-aging product in early 2009.      At that time, CEO Truman Hunt told IBD that this represented&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/cSj3zYfPPDE" height="1" width="1"/&gt;</description>
      <pubDate>Sat, 20 Apr 2013 01:34:00 Z</pubDate>
      <a10:updated>2013-04-20T12:09:33Z</a10:updated>
      <author>Investor's Business Daily</author>
      <nasdaq:tickers>NUS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/is-nu-skin-poised-to-revive-faster-earnings-growth-cm238843</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/international-flavors-fragrances-issues-notes-analyst-blog-cm232898">
      <guid isPermaLink="false">232898</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FS9uUscOQ0E/international-flavors-fragrances-issues-notes-analyst-blog-cm232898</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>International Flavors &amp; Fragrances Issues Notes - Analyst Blog</title>
      <description>Flavors and fragrances major,  International Flavors &amp;amp; Fragrances Inc.  (  IFF  ) is all set to raise funds through debt issuance and recently priced $300 million worth of Senior Notes.&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/FS9uUscOQ0E" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 02 Apr 2013 22:20:45 Z</pubDate>
      <a10:updated>2013-04-02T19:24:16Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AVP</nasdaq:tickers>
      <nasdaq:tickers>IFF</nasdaq:tickers>
      <nasdaq:tickers>IPAR</nasdaq:tickers>
      <nasdaq:tickers>NUS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/international-flavors-fragrances-issues-notes-analyst-blog-cm232898</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/gabelli-buys-ompi-as-valeant-offers-to-buy-obagi-cm232073">
      <guid isPermaLink="false">232073</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EettcOFkXKM/gabelli-buys-ompi-as-valeant-offers-to-buy-obagi-cm232073</link>
      <category>Investing</category>
      <title>Gabelli Buys OMPI as Valeant Offers to Buy Obagi</title>
      <description>Last week when Canada's largest drugmaker, Valeant Pharmaceuticals International Inc.  (  VRX  )  , offered to buy Obagi Medical Products Inc.  (  OMPI  )  for about $344 million, stocks&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/EettcOFkXKM" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 29 Mar 2013 18:24:35 Z</pubDate>
      <a10:updated>2013-03-29T15:25:08Z</a10:updated>
      <author>Sally Jones</author>
      <nasdaq:tickers>GBL</nasdaq:tickers>
      <nasdaq:tickers>NUS</nasdaq:tickers>
      <nasdaq:tickers>OMPI</nasdaq:tickers>
      <nasdaq:tickers>VRX</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/gabelli-buys-ompi-as-valeant-offers-to-buy-obagi-cm232073</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/billionaires-love-nu-skin-cm230653">
      <guid isPermaLink="false">230653</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d_0QIONzZx4/billionaires-love-nu-skin-cm230653</link>
      <category>Investing</category>
      <title>Billionaires Love Nu Skin</title>
      <description>Any research that mentions our "Youth Gene Clusters" sounds very promising, especially if we believe we can stimulate our youth genes to turn back the hands of time and live longer,&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/d_0QIONzZx4" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 26 Mar 2013 02:24:53 Z</pubDate>
      <a10:updated>2013-03-25T23:26:21Z</a10:updated>
      <author>Sally Jones</author>
      <nasdaq:tickers>NUS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/billionaires-love-nu-skin-cm230653</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/avon-upgraded-to-strong-buy-analyst-blog-cm229377">
      <guid isPermaLink="false">229377</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PZ82ZOwvQjw/avon-upgraded-to-strong-buy-analyst-blog-cm229377</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Avon Upgraded to Strong Buy - Analyst Blog</title>
      <description>On Mar 19, Zacks Investment Research upgraded  Avon Products Inc  . (  AVP  ) to a Zacks Rank #1 (Strong Buy).   Why the Upgrade?   Avonhas been witnessing rising earnings estimates on the back&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/PZ82ZOwvQjw" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 21 Mar 2013 18:31:42 Z</pubDate>
      <a10:updated>2013-03-21T15:36:16Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AVP</nasdaq:tickers>
      <nasdaq:tickers>EL</nasdaq:tickers>
      <nasdaq:tickers>IFF</nasdaq:tickers>
      <nasdaq:tickers>NUS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/avon-upgraded-to-strong-buy-analyst-blog-cm229377</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/iff-retains-a-neutral-stance-analyst-blog-cm217349">
      <guid isPermaLink="false">217349</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ODJz8OECuWI/iff-retains-a-neutral-stance-analyst-blog-cm217349</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>IFF Retains a Neutral Stance - Analyst Blog</title>
      <description>We currently maintained a Neutral recommendation on New York-based  International Flavors &amp;amp; Fragrances Inc.  (  IFF  ). Long-term growth prospects are compelling for the company, though&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/ODJz8OECuWI" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 13 Feb 2013 23:10:01 Z</pubDate>
      <a10:updated>2013-02-13T20:51:50Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>HELE</nasdaq:tickers>
      <nasdaq:tickers>IFF</nasdaq:tickers>
      <nasdaq:tickers>IPAR</nasdaq:tickers>
      <nasdaq:tickers>NUS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/iff-retains-a-neutral-stance-analyst-blog-cm217349</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/avons-earnings-recover-in-4q-analyst-blog-cm216831">
      <guid isPermaLink="false">216831</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I31nJJxpsPk/avons-earnings-recover-in-4q-analyst-blog-cm216831</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>Avon's Earnings Recover in 4Q - Analyst Blog</title>
      <description>After reporting dismal results over the past six quarters,  Avon Products Inc.  (  AVP  ) posted better-than-expected sales and earnings results for the fourth quarter and full year 2012. The&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/I31nJJxpsPk" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 12 Feb 2013 21:43:01 Z</pubDate>
      <a10:updated>2013-02-12T17:51:21Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AVP</nasdaq:tickers>
      <nasdaq:tickers>EPS</nasdaq:tickers>
      <nasdaq:tickers>IPAR</nasdaq:tickers>
      <nasdaq:tickers>LRLCY</nasdaq:tickers>
      <nasdaq:tickers>NUS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/avons-earnings-recover-in-4q-analyst-blog-cm216831</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/multi-level-marketing-earnings-reports-real-time-insight-cm214328">
      <guid isPermaLink="false">214328</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rv2M7kv77Zk/multi-level-marketing-earnings-reports-real-time-insight-cm214328</link>
      <category>Investing</category>
      <category>Earnings</category>
      <title>Multi Level Marketing Earnings Reports - Real Time Insight</title>
      <description>Multi Level Marketing firms have been under fire of late.  The one the captures most of the spotlight is Herbalife (HLF) which is to focal point of a battle of big bullies Bill Ackman and&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/rv2M7kv77Zk" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 06 Feb 2013 01:33:01 Z</pubDate>
      <a10:updated>2013-02-05T21:50:54Z</a10:updated>
      <author>Brian Bolan</author>
      <nasdaq:tickers>HLF</nasdaq:tickers>
      <nasdaq:tickers>NUS</nasdaq:tickers>
      <nasdaq:tickers>USNA</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/multi-level-marketing-earnings-reports-real-time-insight-cm214328</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/loeb-rumored-to-short-nu-skin-herbalife-rival-cm209708">
      <guid isPermaLink="false">209708</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qcHQL8ot5O8/loeb-rumored-to-short-nu-skin-herbalife-rival-cm209708</link>
      <category>Investing</category>
      <title>Loeb Rumored to Short Nu Skin, Herbalife Rival</title>
      <description>After taking an 8 percent stake in Herbalife (  HLF  ) earlier this month, a company that's on several hedge fund managers' shorting lists, including Pershing Square's  Bill Ackman  , activist&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/qcHQL8ot5O8" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 23 Jan 2013 05:14:38 Z</pubDate>
      <a10:updated>2013-01-23T01:14:58Z</a10:updated>
      <author>Dianne Tordillo</author>
      <nasdaq:tickers>HLF</nasdaq:tickers>
      <nasdaq:tickers>NUS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/loeb-rumored-to-short-nu-skin-herbalife-rival-cm209708</feedburner:origLink></item>
  </channel>
</rss>
